Sonoma Pharmaceuticals EV 2011-2026 | SNOA

EV Jährlich Sonoma Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.57 M	5.56 M	8.37 M	2.76 M	13.4 M	9.67 M	7.59 M	11 M	15.5 M	12.5 M	4.29 M	23.8 M	26.8 M	33.6 M	53.8 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
53.8 M	2.76 M	15.7 M

EV anderer Aktien in der Arzneimittelhersteller

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
Evoke Pharma EVOK	-3.12 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	-974 M	-	-0.1 %	$ 2.03 B	Schweden
AcelRx Pharmaceuticals ACRX	6.79 M	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	-11 M	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	28.5 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	737 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	25.3 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	197 M	-	-	$ 142 M	USA
Cumberland Pharmaceuticals CPIX	126 M	$ 5.53	2.22 %	$ 82.1 M	USA
Cronos Group CRON	-1.35 M	$ 2.67	2.3 %	$ 1.02 B	Canada
Harrow Health HROW	2.21 B	$ 30.86	0.59 %	$ 1.13 B	USA
Athenex ATNX	209 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	756 M	-	-	$ 2.06 B	France
Catalent CTLT	16.7 B	-	-	$ 11.5 B	USA
HEXO Corp. HEXO	284 M	-	2.45 %	$ 38.1 M	Canada
Eagle Pharmaceuticals EGRX	457 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	-710 M	-	-	$ 28.9 M	Irlanda
Bausch Health Companies BHC	29.9 B	$ 5.5	3.29 %	$ 2.01 B	Canada
Organogenesis Holdings ORGO	408 M	$ 2.55	4.94 %	$ 323 M	USA
Pacira BioSciences PCRX	1.68 B	$ 23.0	3.09 %	$ 1.06 B	USA
Canopy Growth Corporation CGC	459 M	$ 1.03	4.06 %	$ 111 M	Canada
Solid Biosciences SLDB	616 M	$ 6.47	6.41 %	$ 566 M	USA
Aurora Cannabis ACB	330 M	$ 3.47	5.15 %	$ 190 M	Canada
Jupiter Wellness JUPW	3.7 M	-	-	$ 33.6 M	USA
Lannett Company LCI	648 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	146 M	$ 1.07	2.88 %	$ 102 M	Canada
Tilray TLRY	1.96 B	$ 5.41	3.84 %	$ 3.34 B	Canada
Evolus EOLS	467 M	$ 6.59	2.49 %	$ 425 M	USA
Sundial Growers SNDL	-17.5 M	$ 1.44	4.35 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	1.2 B	$ 8.15	0.93 %	$ 417 M	USA
Veru VERU	80.7 M	$ 2.17	2.84 %	$ 31.8 M	USA
Neoleukin Therapeutics NLTX	-80.1 M	-	-	$ 193 M	Canada
cbdMD YCBD	4.51 M	$ 0.75	-0.27 %	$ 3.02 M	USA
Assertio Holdings ASRT	238 M	$ 23.44	0.13 %	$ 150 M	USA
ProPhase Labs PRPH	145 M	-	-	$ 5.07 M	USA
Radius Health RDUS	715 M	-	-	$ 1.42 B	USA
PetIQ PETQ	280 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	251 M	$ 7.17	1.99 %	$ 283 M	USA
Recro Pharma REPH	220 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	312 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	26.3 M	$ 0.67	1.67 %	$ 33.5 M	USA
PLx Pharma PLXP	75 M	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	21.2 B	$ 16.59	2.6 %	$ 19.3 B	USA
Zomedica Corp. ZOM	2.62 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	-22.6 M	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	43.3 M	$ 0.82	2.71 %	$ 29.5 M	USA
Tricida TCDA	555 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	10.7 M	$ 0.71	-0.99 %	$ 3.05 M	China
TherapeuticsMD TXMD	26.3 M	$ 2.08	1.96 %	$ 24.1 M	USA